Candel Therapeutics, Inc.
CADL • NASDAQ
Candel Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul-Peter Tak, with a market cap of $352.3M.
Market Cap$352.3M
Employees42.0
CEOPaul-Peter Tak
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
CAD
Candel Therapeutics, Inc. FAQ
Common questions about Candel Therapeutics, Inc.
Candel Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026.
Candel Therapeutics, Inc. has approximately 42 employees.